Dr. Kelly has spent 30 years at National Cancer Institute-designated cancer centers transforming pediatric cancer care, outcomes and research. Now, as the Waldemar J. Kaminski Endowed Chair of Pediatrics at Roswell Park Comprehensive Cancer Center and chief of pediatric hematology/oncology at the University at Buffalo, she has expanded the Roswell Park Oishei Children’s cancer and blood disorders program to include a pediatric experimental therapeutics program, precision medicine and integrative wellness. The collaborative program now sees more than 90% of pediatric oncology and pediatric benign hematology cases in Western New York, offering cutting-edge clinical trials, stem cell transplants, cell and gene therapies, and specialized treatments for sickle cell disease and hematological conditions. The recipient of the 2023 Lymphoma Research Foundation’s “Distinguished Leadership Award”, she has set new treatment standards for high-risk Hodgkin lymphoma in children and young adults as the leader of multiple national clinical trials. A champion of health equity, Dr. Kelly works to ensure all children have access to high-quality care. She plays a pivotal role in shaping national treatment guidelines as chair of the National Comprehensive Cancer Network pediatric Hodgkin Lymphoma panel and is the founding co-chair of the Lymphoma Research Foundation’s adolescent and young adult consortium.
